30.11.2022 - PALO ALTO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) - 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that the Company and its regulatory consultants from the US and the UK, met with the UK Medicines . Seite 1